Abstract:Background: Helicobacter pylori (H. pylori) infection is closely correlated with chronic gastritis and peptic ulcer disease. However, triple therapy which is widely applied in clinical practice is not effective on eradicating H. pylori in a certain proportion of patients. Aims: To investigate the clinical factors influencing H. pylori eradication in patients with chronic gastritis. Methods: Endoscopic biopsy specimens from 128 H. pylori-positive chronic gastritis patients were taken for H. pylori culture and antibiotic sensitivity test. Patients were treated by triple therapy including omeprazole, metronidazole and clarithromycin for 7 days. CYP2C19 genotype was determined by PCR-RFLP. Effect of various factors on H. pylori eradication rate was analyzed. Results: A total of 123 patients had completed a course of treatment, H. pylori eradication rates by ITT analysis and by PP analysis were 66.4% and 69.1%, respectively. The resistance rates of H. pylori to metronidazole and clarithromycin were 48.4% and 14.1%, respectively. The eradication rate of H. pylori in smokers was significantly lower than that in non-smokers (37.0% vs. 88.3%, P<0.01). The eradication rates of metronidazole-sensitive and clarithromycin-sensitive strains were significantly higher than those of metronidazole-resistant and clarithromycin-resistant strains (90.5% vs. 46.7%, P<0.01; 76.6% vs. 18.8%, P<0.01). The eradication rate of H. pylori in CYP2C19 extensive metabolizers was significantly lower than that in poor metabolizers (63.4% vs. 86.7%, P<0.05). Age, gender and alcohol consumption did not significantly effect the eradication rate of H. pylori (all P>0.05). Conclusions: Resistance of H. pylori to antibiotics and CYP2C19 extensive metabolizer are two important factors causing H. pylori eradication failure. Smoking also increases the failure rate of H. pylori eradication.

Analysis of Clinical Factors Influencing Helicobacter pylori Eradication in Chronic Gastritis Patients